{
    "Trade/Device Name(s)": [
        "Distinct\u00ae Early Detection Pregnancy Test"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K193318",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123436"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "July 22, 2020",
    "Summary Letter Received Date": "July 23, 2020",
    "Submission Date": "August 18, 2020",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Immunochromatographic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Distinct\u00ae Early Detection Pregnancy Test, an over-the-counter chromatographic immunoassay for qualitative detection of hCG in urine.",
    "Indications for Use Summary": "Aid for the early detection of pregnancy intended for home use; performs qualitative detection of hCG in urine as early as 6 days before the missed period.",
    "fda_folder": "Clinical Chemistry"
}